6-Chloro-3-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine

Catalog No. :
ACJLCA459
CAS No. :
1094260-22-6
Molecular Formula :
C11H6ClFN4
Molecular Weight :
248.65

IUPAC Name:6-chloro-3-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine

6-Chloro-3-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$102.00Login to see priceInquiryInquiry
250mg95%$170.00Login to see priceInquiryInquiry
1g95%$661.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-3-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine
IUPAC Name6-chloro-3-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine
MDL No.MFCD11182541
Molecular FormulaC11H6ClFN4
Molecular Weight248.65
SMILESFC1=CC=C(C2=NN=C3C=CC(Cl)=NN32)C=C1
InChI KeyXUXPGXZBMMPANM-UHFFFAOYSA-N
Synonym6-chloro-3-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazine;1,2,4-Triazolo[4,3-b]pyridazine, 6-chloro-3-(4-fluorophenyl)-
CAS No.1094260-22-6
PubChem CID43144342

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJLCA459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLCA459 route product structure diagram
    ACJLCA4591094260-22-6
Inquiry

2. ACJLCA459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLCA459 route product structure diagram
    ACJLCA4591094260-22-6
Inquiry

Comments (0)